Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
top of page
Search
Glenn Hearson
- Nov 9, 2020
PONENTE study hits the mark in phase IIIb asthma trial
PONENTE Phase IIIb open-label Fasenra (benralizumab)
106
Glenn Hearson
- Jul 20, 2020
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
257
Glenn Hearson
- Jul 14, 2020
Major UK research study into the long-term health impacts of COVID-19 on hospitalised patients
Major UK research study into the long-term health impacts of COVID-19 on hospitalised patients
43
Glenn Hearson
- May 20, 2020
ACCORD: Study to Assess Multiple Candidate Agents for the Treatment COVID-19
ACCORD: Study to Assess Multiple Candidate Agents for the Treatment #COVID-19
61
Glenn Hearson
- Apr 14, 2020
Clinical Trial of Interferon beta (IFN-beta) in patients with SARS-CoV-2 (COVID19) is now underway
Clinical Trial of Interferon beta (IFN-beta) in patients with SARS-CoV-2 (COVID19) is now underway
1,641
Glenn Hearson
- Nov 22, 2019
Research to reduce asthma attacks: (MANDALA) Study
We are now recruiting for a new study looking into study of an investigational drug called PT027.
315
Glenn Hearson
- Aug 2, 2019
NIHR Nottingham BRC Study, "Airways Infection in Bronchiectasis" has now fully recruited to target
The study aims to explore the feasibility of collecting and analysing samples to investigate the microbiological causes of exacerbations
144
bottom of page